Joergen Rungby

One Week’s Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and α- and β-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes

Kristine B. Degn, Claus Bogh Juhl, Jeppe Sturis et al. · Diabetes · 2004 · 424 citations · Full text

Effects of the Long-Acting Human Glucagon-Like Peptide-1 Analog Liraglutide on β-Cell Function in Normal Living Conditions

Andrea Mari, Kristine B. Degn, Birgitte Brock et al. · Diabetes Care · 2007 · 83 citations · Full text

Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes

Michael Gejl, Hanne Maare Søndergaard, Chalotte Willemann Stecher et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 77 citations · Full text

Risk and Short-Term Prognosis of Myocardial Infarction Among Users of Antidiabetic Drugs

Søren Paaske Johnsen, T.B.M. Monster, M.L. Olsen et al. · American Journal of Therapeutics · 2006 · 73 citations

Heart Failure, Pharmacotherapy, Acute Myocardial Infarction +16

An experimental study on silver in the nervous system and on aspects of its general cellular toxicity.

Joergen Rungby · PubMed · 1990 · 47 citations

Neurotoxicology, Cell Death, Nanotoxicology +22